You are here

Article Text

Article menu
Download PDFPDF
Harm
Cohort study
Exposure to diagnostic levels of radiation prior to age 30 increases the risk of breast cancer in BRCA1/2 carriers
  1. Bruce G Haffty1,
  2. Carol Lee2
  1. 1Department of Radiation Oncology, Cancer Institute of New Jersey, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA
  2. 2Memorial Sloan Kettering, New York, New York, USA
  1. Correspondence to : Dr Bruce G Haffty
    Department of Radiation Oncology, Cancer Institute of New Jersey, UMDNJ-Robert Wood Johnson Medical School, 195 Little Albany St, New Brunswick, NJ 08903-2681, USA; hafftybg{at}umdnj.edu

https://doi.org/10.1136/eb-2012-101075

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Commentary on: Pijpe A, Andrieu N, Easton DF, et al., on behalf of GENEPSO, EMBRACE, and HEBON. Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK). BMJ 2012;345:e5660.OpenUrlAbstract/FREE Full Text

    Context

    As BRCA1/2 are involved in DNA repair, it has been postulated that carriers may have increased radiosensitivity and increased risk of radiation-induced cancers from diagnostic imaging studies. There are conflicting data from previous studies addressing this.

    Methods

    This study evaluated the risk of breast cancer as a function of ever or never having been exposed to diagnostic levels of radiation prior to age 30 in a retrospective cohort study of 1993 BRCA1/2 carriers, of whom 848 (43%) had a diagnosis of breast cancer at the time of the study. Exposure was determined from self-reported patient surveys and estimated dose levels from procedures determined from available literature. …

    View Full Text

    Footnotes

    • Funding None.

    • Competing interests None.